Description
ROUTE OF ADMINISTRATION
Subcutaneous injection.
IMMUNIZATION SCHEDULE
At 9 months of Age
COMPOSITION
Each single human dose when reconstituted in a volume of 0.5ml contains not less than 1000 CCID50 of live Measles virus particles.
M-VAC
M-VAC
For active immunization against Measles administered to children and adolescents who have been vaccinated before or have had measles infection earlier
Related products
